Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EKB-569 in Advanced Non-Small Cell Lung Cancer
NCT00067548Phase 2Completed
- Sponsor
- Pfizer
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of pelitinib in non-small cell lung cancer (NSCLC), sponsored by Pfizer. Primary endpoint: Clinical Activity. Status: completed.
02
Drugs
pelitinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00067548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067548.